Cytosorbents (CTSO) Interest & Investment Income (2010 - 2026)
Cytosorbents' (CTSO) quarterly Interest & Investment Income came in at -$868000.0 in Q2 2026, down 40.91% on a YoY basis from -$1.5 million in Q2 2025, and down 1.28% quarter-over-quarter from -$857000.0 in Q1 2026.
Powered by 
Analysis
Cytosorbents (CTSO) Interest & Investment Income (2010 - 2026) Analysis & Trends
Cytosorbents (CTSO) has reported Interest & Investment Income for 17 consecutive years, with -$868000.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Interest & Investment Income fell 40.91% year-over-year to -$868000.0; the trailing twelve-month figure through Jun 2026 stood at -$3.1 million (down 28.07% YoY), and the FY2025 full-year result was -$2.6 million, down 86.7% from the prior year.
- Interest & Investment Income slipped to -$868000.0 in Q2 2026 per CTSO's latest filing, from -$857000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $53748.0 in Q4 2022 and bottomed at -$868000.0 in Q2 2026.
- Historically, Interest & Investment Income has averaged -$320052.8 across 5 years, with a median of -$121585.0 in 2023.
- The sharpest annual moves came in 2022 and 2025: Interest & Investment Income soared 337.19% in 2022, then slumped 8993.64% in 2025.
- Over 5 years, Interest & Investment Income stood at $53748.0 in 2022, then plunged by 197.17% to -$52229.0 in 2023, then plunged by 1094.74% to -$624000.0 in 2024, then decreased by 19.55% to -$746000.0 in 2025, then fell by 16.35% to -$868000.0 in 2026.
- According to Business Quant data, Interest & Investment Income over the past three periods registered -$868000.0, -$857000.0, and -$746000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 52.00 Mn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | - |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 30.00 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | - |
| 10 | Cytosorbents | 20.00 Mn | 15.59 Mn | 7.05 Mn | -868,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -868,000.00 |
| Mar 31, 2026 | -857,000.00 |
| Dec 31, 2025 | -746,000.00 |
| Sep 30, 2025 | -645,000.00 |
| Jun 30, 2025 | -616,000.00 |
| Mar 31, 2025 | -605,000.00 |
| Dec 31, 2024 | -624,000.00 |
| Sep 30, 2024 | -588,000.00 |
| Jun 30, 2024 | -180,000.00 |
| Mar 31, 2024 | -6,653.00 |
| Dec 31, 2023 | -52,229.00 |
| Sep 30, 2023 | -33,670.00 |
| Jun 30, 2023 | -8,821.00 |
| Mar 31, 2023 | -63,170.00 |
| Dec 31, 2022 | 53,748.00 |
| Sep 30, 2022 | 46,845.00 |
| Jun 30, 2022 | 23,973.00 |
| Mar 31, 2022 | 8,027.00 |
| Dec 31, 2021 | 12,294.00 |
| Sep 30, 2021 | 12,766.00 |